Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 10, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals on March 9, 2006, at a price of GBP 15.67 per share through the Company's ShareReward Plan. The transactions involved both personal contributions and company matching contributions:
- Mr J S Heslop: Acquired 8 shares (personal) and 8 shares (company match).
- Mr R Bondy: Acquired 8 shares (personal) and 8 shares (company match).
- Mr A P Witty: Acquired 8 shares (personal) and 8 shares (company match).
- Mrs J V Younger: Acquired 8 shares (personal) and 8 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Investor Verification Points
- Verify the share price of GBP 15.67 against market data for March 9, 2006.
- Confirm the total number of shares acquired by each named individual (16 shares total per person).
- Review the terms of the ShareReward Plan entered into on October 5, 2001, to understand the matching contribution structure.